315 related articles for article (PubMed ID: 19292090)
21. [Laparoscopic transhiatal extended gastrectomy for type II, III esophagogastric junction cancer: a preliminary report of 55 cases].
Wang ZQ; Zhang YC; Zhang Q; Zhu XJ; Shu Y; Zhou ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Sep; 13(9):652-5. PubMed ID: 20878569
[TBL] [Abstract][Full Text] [Related]
22. [Extent of radical surgery in cardia carcinoma--esophagectomy or gastrectomy?].
Hölscher AH; Bollschweiler E; Beckurts KT; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():169-72. PubMed ID: 9101821
[TBL] [Abstract][Full Text] [Related]
23. Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.
Hölscher AH; Bollschweiler E; Fetzner UK; Babic B
Updates Surg; 2023 Feb; 75(2):329-333. PubMed ID: 36001282
[TBL] [Abstract][Full Text] [Related]
24. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
25. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.
Siewert JR; Feith M; Stein HJ
J Surg Oncol; 2005 Jun; 90(3):139-46; discussion 146. PubMed ID: 15895452
[TBL] [Abstract][Full Text] [Related]
26. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
[TBL] [Abstract][Full Text] [Related]
27. Surgical approach and results of surgery in adenocarcinoma of the gastro-oesophageal junction.
Ti TK
Singapore Med J; 2000 Jan; 41(1):14-8. PubMed ID: 10783674
[TBL] [Abstract][Full Text] [Related]
28. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
[TBL] [Abstract][Full Text] [Related]
29. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
[TBL] [Abstract][Full Text] [Related]
30. Surgical treatment of adenocarcinomas of the gastro-esophageal junction.
Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Ruurda JP; van Hillegersberg R
Ann Surg Oncol; 2015 Feb; 22(2):597-603. PubMed ID: 25190126
[TBL] [Abstract][Full Text] [Related]
31. Authors' reply: Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction (Br J Surg 2013; 100: 1050-1054).
Mine S; Sano T
Br J Surg; 2014 May; 101(6):735-6. PubMed ID: 24723024
[No Abstract] [Full Text] [Related]
32. Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction.
Reeh M; Mina S; Bockhorn M; Kutup A; Nentwich MF; Marx A; Sauter G; Rösch T; Izbicki JR; Bogoevski D
Br J Surg; 2012 Oct; 99(10):1406-14. PubMed ID: 22961520
[TBL] [Abstract][Full Text] [Related]
33. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors.
Sauvanet A; Mariette C; Thomas P; Lozac'h P; Segol P; Tiret E; Delpero JR; Collet D; Leborgne J; Pradère B; Bourgeon A; Triboulet JP
J Am Coll Surg; 2005 Aug; 201(2):253-62. PubMed ID: 16038824
[TBL] [Abstract][Full Text] [Related]
34. [What kind of surgical radicality is justified in the treatment of esophageal and cardial carcinoma?].
Vörös A; Altorjay A; Nagy P; Jakkel T; Bohák A; Szántó I; Gamal EM; Kiss J
Zentralbl Chir; 2001 Oct; 126(10):756-62. PubMed ID: 11727183
[TBL] [Abstract][Full Text] [Related]
35. [Adenocarcinoma of the esophagogastric junction (AEG-tumor). Review of the literature].
Pilco J; Stein J
Rev Gastroenterol Peru; 2006; 26(2):194-9. PubMed ID: 16865166
[TBL] [Abstract][Full Text] [Related]
36. Surgical therapy of adenocarcinoma of the esophagogastric junction: analysis of prognostic factors.
Di Martino N; Izzo G; Cosenza A; Cerullo G; Torelli F; Monaco L; Basciotti A; del Genio A
Hepatogastroenterology; 2005; 52(64):1110-5. PubMed ID: 16001641
[TBL] [Abstract][Full Text] [Related]
37. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction (Br J Surg 2013; 100: 1050-1054).
Polkowski WP; van Lanschot JJ
Br J Surg; 2014 May; 101(6):735. PubMed ID: 24723025
[No Abstract] [Full Text] [Related]
38. Surgical management of and long-term survival after adenocarcinoma of the cardia.
Mariette C; Castel B; Toursel H; Fabre S; Balon JM; Triboulet JP
Br J Surg; 2002 Sep; 89(9):1156-63. PubMed ID: 12190682
[TBL] [Abstract][Full Text] [Related]
39. Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy.
Gianotti L; Braga M; Landoni L; Mari G; Scaltrini F; Di Castelnuovo A; Di Carlo V
Hepatogastroenterology; 2003; 50(54):1948-52. PubMed ID: 14696439
[TBL] [Abstract][Full Text] [Related]
40. [Surgical treatment of Barrett carcinoma].
Fuchs KH
Zentralbl Chir; 2000; 125(5):443-9. PubMed ID: 10929629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
